High-Cost Drugs: A CEO’s Perspective
Two health plan CEOs will explore their thoughts on how high drug prices impact both insurers and the overall health care system. The Robert Wood Johnson Foundation’s Susan Dentzer will moderate the discussion, which will include an interactive Q&A.